Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Allotransplantation Stories

2013-12-30 23:04:26

Navy Corpsman Joins 29 Organ and Tissue Transplant Recipients as Float Riders to Demonstrate Appreciation of Life-Saving Donor Gifts Alachua, FL (PRWEB) December 30, 2013 AxoGen, Inc. (NASDAQ: AXGN), a leading regenerative medicine company focused on the development and commercialization of products and technologies for peripheral nerve reconstruction and regeneration, today announced that Navy Corpsman Edward Bonfiglio, a patient who received limb sparing surgery utilizing AxoGen’s...

2013-12-30 04:20:18

HORSHOLM, Denmark, Dec. 30, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of Envarsus(®) (formerly LCP-Tacro(TM)) for the prevention of organ rejection in kidney transplant recipients. The submission is based on the entire data set from the company's clinical development program that comprised 25 studies and...

2013-12-24 08:23:55

HORSHOLM, Denmark, Dec. 24, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that Envarsus(® )was granted Orphan Drug status by the U.S. Food and Drug Administration (FDA) for prophylaxis of organ rejection in patients receiving allogenic kidney transplants. The designation is to encourage the development of drugs that may provide significant benefit to patients suffering from rare diseases. Envarsus(®) is Veloxis' once-daily formulation of tacrolimus...

2013-12-20 08:26:06

NEW YORK, Dec. 20, 2013 /PRNewswire/ -- Those who have leukemia, lymphoma or other blood cancer diseases might have heard about bone marrow transplant as a potential treatment. As with any serious procedure, it is important to have all questions answered by a physician before any decision is made. Below are four important questions to ask during a doctor's visit. * What is a bone marrow transplant? First, patients undergo chemotherapy and sometimes radiation to destroy their...

2013-12-12 12:27:38

6 of 8 Medicare Administrative Contractors Now Cover MiMedx EpiFix® Wound Care Allografts MARIETTA, Ga., Dec. 12, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that Medicare contractor, CGS, has confirmed that the Company's wound care allograft, EpiFix®, has received reimbursement coverage from CGS. The...

2013-12-10 08:27:09

An organ recipient and a tissue recipient to represent Colorado and the possibilities of transplantation aboard the annual Donate Life Rose Parade Float DENVER, Dec. 10, 2013 /PRNewswire/ -- Two Coloradans that received gifts of life-saving and life-healing organ and tissue transplants will be among 30 individuals from around the country riding aboard the eleventh annual Donate Life Float in the nationally televised Rose Parade on January 1 in Pasadena, CA. The 2014 Donate Life float, Light...

2013-12-09 10:43:09

Hematopoietic stem cell transplantation (HSCT), once considered an effective yet risky alternative to drug therapy for blood cancer, has become more accessible and successful in a wide range of patients as a result of major advances in transplant strategies and technologies. Several studies representing these advances were presented today during the 55th American Society of Hematology Annual Meeting and Exposition in New Orleans. HSCT is effectively used today as a form of "replacement"...

2013-12-09 10:11:07

8 of 9 children treated doing well, according to data presented to American Society of Hematology Hematopoietic stem cell transplantation (HSCT), once considered an effective yet risky alternative to drug therapy for blood cancer, has become more accessible and successful in a wide range of patients as a result of major advances in transplant strategies and technologies. Several studies representing these advances were presented today during the 55th American Society of Hematology Annual...

Blood Vessels Reorganize Themselves After Face Transplantation Surgery
2013-12-04 12:19:55

Radiological Society of North America For the first time, researchers have found that the blood vessels in face transplant recipients reorganize themselves, leading to an understanding of the biologic changes that happen after full face transplantation. The results of this study were presented today at the annual meeting of the Radiological Society of North America (RSNA). Face transplantation is a recent development in reconstructive surgery for patients who have lost some or all of...

2013-12-04 00:21:04

CHICAGO, Dec. 4, 2013 /PRNewswire-USNewswire/ -- For the first time, researchers have found that the blood vessels in face transplant recipients reorganize themselves, leading to an understanding of the biologic changes that happen after full face transplantation. The results of this study were presented today at the annual meeting of the Radiological Society of North America (RSNA). Face transplantation is a recent development in reconstructive surgery for patients who have lost some or all...